UK markets closed

FSD Pharma Inc. (HUGE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3000-0.0070 (-2.28%)
At close: 04:00PM EDT
0.2979 -0.00 (-0.70%)
After hours: 07:35PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-23,806
-17,902
-23,607
-35,285
-31,800
-
Depreciation & amortisation
4,488
2,506
4,535
4,046
3,900
-
Stock-based compensation
1,366
3,835
1,531
7,444
8,052
-
Change in working capital
-4,813
1,638
-7,120
2,889
807.136
-
Accounts receivable
-
-
-
-
-
-1,079
Inventory
-
-
-
-
-
-721.8561
Accounts payable
-
-
-
-
-
825.12
Other working capital
-26,417
-10,827
-28,697
-21,246
-19,130
-
Other non-cash items
-32.56
-4,915
-78.661
19.612
-672.304
-
Net cash provided by operating activities
-26,098
-10,827
-28,333
-20,746
-19,130
-
Cash flows from investing activities
Investments in property, plant and equipment
-318.991
-
-363.958
-500
-
-293.126
Purchases of investments
-766.64
-744.5
-401.612
0
0
-
Sales/maturities of investments
158.036
443.138
158.036
0
6,478
-
Net cash used for investing activities
12,564
-269.579
12,123
268.964
6,514
-
Cash flows from financing activities
Debt repayment
-106.441
-189.054
-143.071
-129.325
-986.636
-
Common stock issued
0
0.034
0
38,341
25,100
-
Common stock repurchased
0
-2,958
-1,926
0
0
-
Other financing activities
-
-
-
-
-
-25.0369
Net cash used provided by (used for) financing activities
-2,033
-3,127
-2,069
38,212
24,173
-
Net change in cash
-15,567
-14,223
-18,279
17,735
11,557
-
Cash at beginning of period
39,315
16,980
35,260
17,525
5,968
-
Cash at end of period
23,748
2,757
16,980
35,260
17,525
-
Free cash flow
Operating cash flow
-26,098
-10,827
-28,333
-20,746
-19,130
-
Capital expenditure
-318.991
-
-363.958
-500
-
-293.126
Free cash flow
-26,417
-10,827
-28,697
-21,246
-19,130
-